Budget Saving Potential of Pegfilgrastim Biosimilar for the Treatment of Chemotherapy-Induced Febrile Neutropenia, in Italy. Farmeconomia. Health Economics and Therapeutic Pathways, [S. l.], v. 23, n. 1, 2022. DOI: 10.7175/fe.v23i1.1516. Disponível em: https://journals.seedstm.com/index.php/FE/article/view/1516. Acesso em: 29 dec. 2025.